Lee Schwartzberg, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Baptist Memorial Hospital-Memphis University of Tennessee Medical Center
New York Medical College
Medical School
North Shore-Long Island Jewish Health System
Residency
Memorial Sloan-Kettering Cancer Center
Fellowship
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
AR State Medical License: 2002 - 2017
MS State Medical License: 1989 - 2017
TN State Medical License: 1987 - 2018
American Board of Internal Medicine: Hematology
American Board of Internal Medicine: Medical Oncology
American Board of Internal Medicine: Internal Medicine
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.
Cortés, J.,Rugo, H. S.,Awada, A.,Twelves, C.,Perez, E. A.,Im, S. A.,Gómez-Pardo, P.,Schwartzberg, L. S.,Diéras, V.,Yardley, D. A.,Potter, D. A.,Mailliez, A.,Moreno-Asp...; Breast Cancer Res. Treat.. 2017 Jun 15.
See more >>Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists.
Bošnjak, S. M.,Gralla, R. J.,Schwartzberg, L.; Support Care Cancer. 2017 Jan 22.
See more >>Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
Chasen M, Urban L, Schnadig I, Rapoport B, Powers D, Arora S, Navari R, Schwartzberg L, Gridelli C; Support Care Cancer. 2017-01-01.
See more >>American Society of Clinical Oncology